[Clinical Efficacy of Allo-HSCT on FLT3-ITD Positive AML Patients].

Wang, Yan-Fang; Huang, Shi-Yang; Zhang, Zhen-Hao; Dong, Fei; Wang, Ying; Jing, Hong-Mei; Ke, Xiao-Yan

Wang, Yan-Fang; Huang, Shi-Yang; Zhang, Zhen-Hao; Dong, Fei; Wang, Ying; Jing, Hong-Mei; Ke, Xiao-Yan.

Afiliação

Wang YF; Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
Huang SY; Department of Immunology, Peking University Health Science Center, and Center for Human Disease Genomics, Beijing 100191, China.
Zhang ZH; Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
Dong F; Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
Wang Y; Department of Immunology, Peking University Health Science Center, and Center for Human Disease Genomics, Beijing 100191, China.
Jing HM; Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
Ke XY; Department of Hematology, Peking University Third Hospital, Beijing 100191, China,E-mail: xiaoyank@ yahoo.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(4): 1183-1188, 2020 Aug.

Article em Zh | MEDLINE | ID: mdl-32798396

Assuntos

Transplante de Células-Tronco Hematopoéticas; Leucemia Mieloide Aguda; Adulto; Humanos; Recidiva Local de Neoplasia; Prognóstico; Resultado do Tratamento; Tirosina Quinase 3 Semelhante a fms

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google